Sign In
Buy GBAB
$14.05
-0.0300 (-0.213%)
At Close: Jun 03, 2026
GBAB: Buy Case Starting To Emerge
08:37am, Friday, 11'th Feb 2022
GBAB has been falling steadily, but a bottom could be at hand.
NBB: Mixed Outlook For The Year Ahead
06:14am, Friday, 14'th Jan 2022
NBB: Mixed Outlook For The Year Ahead
GBAB: Staying Patient Has Paid Off
03:39am, Sunday, 28'th Nov 2021
GBAB traded at a fairly steep premium during my last review, and that made me cautious on the fund. After a sell-off, the fund has a more reasonable valuation, and I continue to find its diversified h
Taxable Munis Deserve Attention
08:24am, Friday, 22'nd Oct 2021
The taxable municipal bond market is growing and mature. Taxable munis offer a range of benefits for certain investors, in particular insurance companies.
GBAB: I Like The Diversity, But The Upside Is Capped
12:38am, Thursday, 09'th Sep 2021
GBAB: I Like The Diversity, But The Upside Is Capped
CEF Report April 2021: A Complete Round Trip
07:00am, Wednesday, 21'st Apr 2021
CEF Report April 2021: A Complete Round Trip
CEF Report: Party Like It's February 2020
06:00am, Friday, 26'th Feb 2021
In this report, we discuss what's happening in the CEF world in terms of valuations which are nearing the tightest levels of the last five years. Investors have a choice. They can be buy-and-hold inve
Guggenheim Taxable Muni: A Quality Fund That Is Slowly Changing
07:00am, Monday, 07'th Dec 2020
GBAB is a great long-term performer with high-quality characteristics. The fund is up over 8.7% YTD on price and 5.3% on NAV. The fund is increasingly venturing into tax-free munis as a way to supplan
Bristol-Myers Squibb Analyst Sees Multiple Expansion Story, Limited Near-Term Downside Risk
12:00am, Monday, 19'th Oct 2020
An analyst at Guggenheim Securities turned bullish on pharma giant Bristol-Myers Squibb Co (NYSE: BMY) Monday, basing their optimism on a revival in sales of its flagship immuno-...
My Income Portfolio - The NAV Evolution
04:29pm, Friday, 16'th Oct 2020
Almost one year ago, I built an income portfolio based on 15 closed-end funds (CEFs) that I judged to have the best net asset value (NAV) performance since inception.
LendingPoint Closes its First Revolving and its Largest Ever Rated Consumer Loan ABS Issuance
12:00am, Friday, 16'th Oct 2020
LendingPoint, the data and technology platform, announced today the closing of its first revolving and largest ever consumer loan ABS issuance.
Horizon Therapeutics: This Stock Has A 'Very Bullish' Rating By Both SA Quant Rating Tool And Wall Street Analysts (NASDAQ:HZNP)
12:25pm, Monday, 12'th Oct 2020
The stock price performance of HZNP has been one of the best in the biotech universe year to date. The launch of Tepezza has been probably the best in the rare disease space ever.
Guggenheimek kultur eta hezkuntza jardueren eskaintza zabala izango du udazkenean
01:44am, Sunday, 11'th Oct 2020
Arte moderno eta garaikidea herritarrei gerturatzea eta artearen eta kulturaren gozamena sustatzea dira egitarauaren helburu nagusiak
Creative Financial Designs Inc. ADV Acquires 1,582 Shares of Blackrock Taxable Municipal Bond Trust (NYSE:BBN)
07:56am, Thursday, 08'th Oct 2020
Creative Financial Designs Inc. ADV lifted its holdings in Blackrock Taxable Municipal Bond Trust (NYSE:BBN) by 33.8% in the third quarter, according to the company in its most recent disclosure with
Array Technologies, Inc. Announces Launch of Initial Public Offering
12:00am, Wednesday, 07'th Oct 2020
Array Technologies, Inc. (the “Company”) today announced that it has launched the roadshow for the initial public offering of its common stock. The Co
